Published in Cathet Cardiovasc Diagn on June 01, 1997
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med (1997) 4.88
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol (1995) 4.10
Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation (1994) 3.30
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv (2000) 2.94
Radiation exposure to patients undergoing diagnostic and interventional cardiac catheterization procedures. Cathet Cardiovasc Diagn (1997) 2.67
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med (1999) 2.19
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18
Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol (2000) 2.12
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation (1986) 2.00
Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med (1991) 1.78
Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. Cathet Cardiovasc Diagn (1994) 1.68
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn (1996) 1.54
Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol (1988) 1.51
Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). Am J Cardiol (2001) 1.50
Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cathet Cardiovasc Diagn (1997) 1.47
Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PCTA) Cathet Cardiovasc Diagn (1998) 1.44
Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol (1995) 1.43
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn (1996) 1.43
Death with dipyridamole-thallium imaging. Ann Intern Med (1988) 1.42
A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1996) 1.41
Coronary thrombosis during acute myocardial infarction: Roberts was right! Am J Cardiol (1998) 1.41
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med (1988) 1.39
Percutaneous triple-valve balloon valvuloplasty in a pregnant woman. Cathet Cardiovasc Diagn (1991) 1.39
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn (1995) 1.39
Valve replacement for tricuspid regurgitation appearing late after healing of left ventricular posterior wall and right ventricular acute myocardial infarction. Am J Cardiol (1994) 1.39
Balloon dilation of mitral stenosis in adult patients: postmortem and percutaneous mitral valvuloplasty studies. J Am Coll Cardiol (1987) 1.34
Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med (1991) 1.28
Cor triatriatum dexter: recognition and percutaneous transluminal correction. Cathet Cardiovasc Diagn (1991) 1.28
Percutaneous mitral valvuloplasty in an adult patient with calcific rheumatic mitral stenosis. J Am Coll Cardiol (1986) 1.23
The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation (1992) 1.21
Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. J Am Coll Cardiol (1987) 1.19
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol (1992) 1.15
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation (1995) 1.14
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol (2001) 1.13
Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2001) 1.11
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol (1997) 1.11
Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines? Am Heart J (2001) 1.09
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol (1999) 1.09
Glidewire treatment of resistant coronary occlusions. Cathet Cardiovasc Diagn (1993) 1.07
Clinical and angiographic results of balloon-expandable intracoronary stents in right coronary artery stenoses. J Am Coll Cardiol (1990) 1.06
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation (1987) 1.06
Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation (1988) 1.06
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol (1999) 1.05
Pulsed Doppler assessment of left ventricular diastolic filling in coronary artery disease before and immediately after coronary angioplasty. Am J Cardiol (1987) 1.04
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol (1998) 1.03
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol (1997) 1.03
Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol (2001) 1.03
Aorto-right ventricular fistula: a late complication of aortic valve replacement. Tex Heart Inst J (1999) 1.03
Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol (1997) 1.02
Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med (1997) 0.99
Continuous positive airway pressure in the prophylaxis of the adult respiratory distress syndrome. Surg Gynecol Obstet (1976) 0.99
Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1993) 0.98
Angioplasty therapy of cardiogenic shock: are randomized trials necessary? J Am Coll Cardiol (1992) 0.98
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. Circulation (1995) 0.97
Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. N Engl J Med (1993) 0.97
Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol (1987) 0.96
Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol (1989) 0.96
Colorectal carcinoma in patients under age 40. Ann Surg (1985) 0.95
Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med (1992) 0.94
Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. J Am Coll Cardiol (1987) 0.94
Prognostic significance of systolic time intervals after recovery from myocardial infarction. Am J Cardiol (1981) 0.94
Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms. Clin Cardiol (1998) 0.94
Assessment of left ventricular and aortic valve function after aortic balloon valvuloplasty in adult patients with critical aortic stenosis. Circulation (1987) 0.93
Early hospital discharge after percutaneous transluminal coronary angioplasty. Am J Cardiol (1989) 0.93
Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol (1991) 0.92
Changing incidence and management of abrupt closure following coronary intervention in the new device era. Cathet Cardiovasc Diagn (1992) 0.91
Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. J Am Coll Cardiol (1987) 0.90
Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol (2000) 0.90
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation (1999) 0.90
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarction. J Am Coll Cardiol (1988) 0.89
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. Am J Cardiol (1986) 0.89
Primary angioplasty. Br Heart J (1995) 0.89
Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation (1989) 0.89
Noninvasive assessment of mitral stenosis before and after percutaneous balloon mitral valvuloplasty. Am J Cardiol (1988) 0.88
Multivessel balloon angioplasty should be abandoned in diabetic patients! J Am Coll Cardiol (1998) 0.88
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Am J Med (1988) 0.87
Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J (1999) 0.87
Primary coronary angioplasty for acute myocardial infarction complicated by out-of-hospital cardiac arrest. Am J Cardiol (1995) 0.87
Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction. Heart (2003) 0.87
A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. J Am Coll Cardiol (1998) 0.87
Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. Am J Cardiol (1989) 0.86